AN2 Therapeutics, Inc
AN2 Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics derived from our boron chemistry platform. Our development pipeline spans hematologic diseases, infectious diseases and oncology, alongside advanced research programs focused on targets in oncology, bone disorders, and infectious diseases.